Maternal plasma homocysteine levels in women with preterm premature rupture of membranes

Medical Hypotheses

Volumn 56, Issue 1, 2001, Pages 85-90

  Ferguson, S E ^a   Smith, G N ^b   Walker, M C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVIEW; VITAMIN INTAKE;

EID: 0035170531     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1116     Document Type: Article

References (59)

1. Homocysteine and coronary atherosclerosis
2. A quantitative assessment of plasma homocysteine asia risk factor for vascular disease: Probable benefits of increasing folic acid intakes
3. Hperhomocysteinemia: A risk factor for placental abruption or infarction
4. Hyperhomocysteinemia: A risk factor in a woman with unexplained recurrent early pregnancy loss
5. Elevated homocysteine levels with preeclampsia
6. Homocysteine metabolism in pregnancies complicated by neural-tube defects
7. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
8. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion
9. Underlying disorder associated with severe preclampsia
10. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
11. The reaction of homocysteine with aldehyde: An explanation of the collagen defects in homocystinuria
12. Effect of induced elevated plasma levels of homocystine and methionine in rats on collagen and elastin structures
13. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria
14. Pathobiochemical implications of hyperhomocysteinemia
15. Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis
16. Clinical chemistry and molecular biology of homocysteine metabolism: An update
17. Homocystinuria: Pathogenetic mechanisms
18. Metabolic abnormalities detected in a survey of mentally backward individuals in northern Ireland
19. Hyperhomocysteinaemia and associated disease
20. Intermediate Homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
21. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
22. Relation between folate status, a common mutation in methylentetrahydrofolate reductase and plasma homocysteine concentrations
23. 12 deficiency than in heterozygosity for homocystinuria due to cystathione B-synthase deficiency
24. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
25. Hyperhomocysteinemia and the response to vitamin supplementation
26. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
27. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction
28. Homocystinemia: Vascular injury and arterial thombosis
29. Hyperhomocysteinemia: An independent risk factor for vascular disease
30. The association of elevated plasma homocysteine with progression of symptomatic peripheral arterial disease
31. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters
32. High prevelance of hyperhomocysteinemia in patients with juvenile venous thrombosis
33. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
34. Neural-tube defects and derangement of homocyteine metabolism
35. Maternal hyperhomocysteinemia a risk factor for neural-tube defects?
36. Vitamin deficiencies and neural tube defects
37. Prevention of neural tube defects; results of the Medical Research Council vitamin study
38. Prevention of the first occurrence of Neural tube defects by periconceptional vitamin supplementation
39. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
40. Decreased methylenetetrahydrofolate reductase activity due to the 1298 A to C mutation in families with NTD affected offspring
41. Open or closed
42. The nature of the intramolecular cross-links in collagen. The separation and characterization of peptides from the cross-link region of rat skin collagen
43. Degradation products from elastin
44. The chemistry of the collagen cross-links
45. A collagen defect in homocystinuria
46. Premature rupture of the fetal membranes
47. The etiology of premature rupture of the membranes
48. Epidemiologic characteristics of preterm delivery: Etiologic heterogeneity
49. Neonatal consequences of preterm PROM
50. Determinants of pretern birth rates in Canada from 1981 through 1983 and from 1992 through 1994
51. Preterm Births in Canada. Where do we go from here?
52. The pathobiology of premature rupture of membranes
53. Etiology of preterm premature rupture of the membranes
54. On the strength of foetal membranes
55. Confocal immunofluorescence localization of collagen types I, III, IV, V, VI and their ultrastructural organization in term human fetal membranes
56. Histological, ultrastructural, and immunofluorescence studies on the amniochorionic membrane
57. Antibiotic inhibition of bacterially induced fetal membrane weakening
58. Ehers-Danlos Syndrome: Associated with prematurity and premature rupture of foetal membranes; possible increase in incidence